Six-month outcomes after restrictive or liberal transfusion for cardiac surgery (TRICS III trial)

Transfus Med. 2019 Apr;29(2):77-79. doi: 10.1111/tme.12596.

Abstract

Clinical question: Is transfusing red cell components using a restrictive transfusion threshold (Hb < 75 g L-1 ) as safe as a liberal transfusion threshold (Hb < 95 g L-1 in intensive care and < 85 g L-1 outside intensive care) during and after cardiac surgery for adults at moderate to high risk of death?

Evidence from trial: In adults undergoing cardiac surgery who were at moderate to high risk for death, using a restrictive red-cell transfusion threshold was as safe as a liberal red cell transfusion threshold (composite outcome of death from any cause, myocardial infarction, stroke or new-onset renal failure with dialysis at 6 months after surgery).

Keywords: cardiac surgery; randomised-controlled trial; red cell transfusions.

Publication types

  • Clinical Trial, Phase III
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Cardiac Surgical Procedures*
  • Critical Care*
  • Erythrocyte Transfusion*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Platelet Transfusion*